Selected article for: "prospective real world study and real world study"
Author: Francis, Nick A; Stuart, Beth; Knight, Matthew; Vancheeswaran, Rama; Oliver, Charles; Willcox, Merlin; Barlow, Andrew; Moore, Michael
Title: Predictors of clinical deterioration in patients with suspected COVID-19 managed in a ‘virtual hospital’ setting: a cohort study
  • Cord-id: 8kpds6dy
  • Document date: 2021_3_23
    • ID: 8kpds6dy
    Snippet: OBJECTIVE: Identify predictors of clinical deterioration in a virtual hospital (VH) setting for COVID-19. DESIGN: Real-world prospective observational study. SETTING: VH remote assessment service in West Hertfordshire NHS Trust, UK. PARTICIPANTS: Patients with suspected COVID-19 illness enrolled directly from the community (postaccident and emergency (A&E) or medical intake assessment) or postinpatient admission. MAIN OUTCOME MEASURE: Death or (re-)admission to inpatient hospital care during VH
    Document: OBJECTIVE: Identify predictors of clinical deterioration in a virtual hospital (VH) setting for COVID-19. DESIGN: Real-world prospective observational study. SETTING: VH remote assessment service in West Hertfordshire NHS Trust, UK. PARTICIPANTS: Patients with suspected COVID-19 illness enrolled directly from the community (postaccident and emergency (A&E) or medical intake assessment) or postinpatient admission. MAIN OUTCOME MEASURE: Death or (re-)admission to inpatient hospital care during VH follow-up and for 2 weeks post-VH discharge. RESULTS: 900 patients with a clinical diagnosis of COVID-19 (455 referred from A&E or medical intake and 445 postinpatient) were included in the analysis. 76 (8.4%) of these experienced clinical deterioration (15 deaths in admitted patients, 3 deaths in patients not admitted and 58 additional inpatient admissions). Predictors of clinical deterioration were increase in age (OR 1.04 (95% CI 1.02 to 1.06) per year of age), history of cancer (OR 2.87 (95% CI 1.41 to 5.82)), history of mental health problems (OR 1.76 (95% CI 1.02 to 3.04)), severely impaired renal function (OR for eGFR <30=9.09 (95% CI 2.01 to 41.09)) and having a positive SARS-CoV-2 PCR result (OR 2.0 (95% CI 1.11 to 3.60)). CONCLUSIONS: These predictors may help direct intensity of monitoring for patients with suspected or confirmed COVID-19 who are being remotely monitored by primary or secondary care services. Further research is needed to confirm our findings and identify the reasons for increased risk of clinical deterioration associated with cancer and mental health problems.

    Search related documents:
    Co phrase search for related documents
    • abnormal normal and acute chronic: 1, 2
    • abnormal normal and logistic regression: 1, 2, 3, 4, 5
    • abnormal normal and logistic regression model: 1, 2, 3, 4
    • abnormal normal and lymphocyte ratio: 1, 2
    • absence presence and absolute risk: 1
    • absence presence and acei enzyme inhibitor: 1
    • absence presence and acute chronic: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • absence presence and acute chronic condition: 1
    • absence presence and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63
    • absence presence and logistic regression model: 1, 2, 3, 4, 5, 6, 7
    • absence presence and low incidence: 1, 2
    • absence presence and lymphocyte ratio: 1, 2, 3
    • absolute risk and acute chronic: 1
    • absolute risk and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • absolute risk and logistic regression model: 1, 2, 3, 4, 5
    • absolute risk and low risk patient: 1, 2
    • absolute risk and lymphocyte ratio: 1, 2, 3